IURISCI, IDA
 Distribuzione geografica
Continente #
NA - Nord America 154
EU - Europa 136
AS - Asia 134
SA - Sud America 17
AF - Africa 1
Totale 442
Nazione #
US - Stati Uniti d'America 154
SG - Singapore 59
CN - Cina 44
UA - Ucraina 31
SE - Svezia 25
IE - Irlanda 24
TR - Turchia 18
GB - Regno Unito 17
BR - Brasile 14
FR - Francia 13
DE - Germania 8
IN - India 7
FI - Finlandia 6
IT - Italia 4
RU - Federazione Russa 4
ES - Italia 2
VE - Venezuela 2
AR - Argentina 1
BD - Bangladesh 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LT - Lituania 1
PL - Polonia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 442
Città #
Singapore 47
Jacksonville 30
Chandler 27
Dublin 24
Southend 14
Princeton 11
Beijing 10
Izmir 10
Nanjing 9
Dallas 8
Dearborn 6
Cambridge 5
Ashburn 4
Boardman 4
Los Angeles 4
Santa Clara 4
Tongling 4
Altamura 3
Hangzhou 3
Nanchang 3
Changsha 2
Frankfurt am Main 2
New York 2
Wilmington 2
Alvorada 1
Ann Arbor 1
Ardabil 1
Augusta 1
Barquisimeto 1
Betim 1
Bishkek 1
Bom Jesus do Tocantins 1
Boston 1
Breaux Bridge 1
Brooklyn 1
Buenos Aires 1
Buffalo 1
Burbank 1
Charlotte 1
Conegliano 1
Cordeirópolis 1
Currais Novos 1
Dehradun 1
Elk Grove Village 1
Foz do Iguaçu 1
Grevenbroich 1
Hanoi 1
Helsinki 1
Itatiba 1
Jiaxing 1
Johannesburg 1
Kunming 1
Lagoa Santa 1
Lanzhou 1
Limeira 1
Madrid 1
Marabá 1
Maricá 1
Palhoça 1
Phoenix 1
Providence 1
San Isidro 1
San Mateo 1
Secaucus 1
Seoul 1
Shenyang 1
Simi Valley 1
Sorocaba 1
Stockholm 1
Thrissur 1
Vera Cruz 1
Warsaw 1
Totale 286
Nome #
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer 100
Concentrations of Galectin-3 in the Sera of Normal Controls and Cancer Patients 99
Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies 87
Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis. 87
Improved tumor control through circadian clock induction by Seliciclib, a cyclin-dependent kinase inhibitor. 75
Totale 448
Categoria #
all - tutte 1.846
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.846


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117 0 0 0 0 0 5 1 0 3 5 3 0
2021/202220 0 0 0 7 2 0 0 1 1 0 3 6
2022/202378 5 7 9 9 8 16 4 6 8 2 2 2
2023/202428 2 2 4 0 0 9 8 0 0 1 0 2
2024/202582 5 25 13 2 0 2 3 3 6 1 7 15
2025/202670 12 16 12 10 15 5 0 0 0 0 0 0
Totale 448